...
首页> 外文期刊>Orthopaedic Journal of Sports Medicine >Platelet Rich Plasma in Arthroscopic Rotator Cuff Repair: Clinical and Radiological Results of A Prospective RCT Study at 10-Year Follow-Up
【24h】

Platelet Rich Plasma in Arthroscopic Rotator Cuff Repair: Clinical and Radiological Results of A Prospective RCT Study at 10-Year Follow-Up

机译:血小板富血浆在关节镜旋转箍修复:临床和放射性术后10年后的预期RCT研究

获取原文

摘要

Objectives: Despite the technical advancement in arthroscopic rotator cuff repair, inadequate healing or retear of the repaired rotator cuff frequently occurs. The use of biological factors in the surgical treatment has been proved to be effective to enhance tendon healing in the post-operative period. The aim of the study is to compare clinical and radiological outcomes of arthroscopic rotator cuff repair with or without the addition of platelet-rich plasma (PRP) at 10-year follow-up. Methods: Of 53 patients recruited in the study, and randomly divided into two groups (PRP=26; control=27), 38 were re-evaluated at least 10 years after the index procedure. The clinical evaluation was carried out through: University of California at Los Angeles (UCLA) Shoulder Score, Visual Analogue Scale (VAS), Simple Shoulder Test (SST), Constant-Murley Score (CMS), Single Assessment Numerical Evaluation (SANE), American Shoulder and Elbow Surgeons (ASES) and isometric strength in abduction and external rotation. Musculoskeletal ultrasound had been used to evaluate the integrity of the repaired cuff. Results: A number of 38 (71%) patients (PRP=17; control=21) with a median age of 71 [64.75-76.50] years have been evaluated. Satisfaction at follow-up is high (90%), without statistically significant difference between the two groups. We report good and excellent clinical results in both groups (PRP vs control): CMS (81.62 [72.47-85.75] vs 77.97 [69.52-82.55] points), UCLA (34 [29.00-35.00] vs 33 [29.00-35.00] points), VAS (0.34 [0.00-1.85] vs 0.70 [0.00-2.45] cm), ASES (100.00 [94.17-100.00] vs 93.33 [68.33-100.00] points), SANE (100 [80-100] vs 80 [70-90] points), SST (12.00 [11.00-12.00] vs 12.00 [9.00-12.00] points),shoulder abduction strength (3.92 ± 2.30 vs 3.20 [1.72-4.65] kg), shoulder external rotation strength (5.31 ± 2.77 vs 4.36 ± 2.05 kg). It was not possible to find a statistically significant difference for the variables analysed, except for few subjective variables (ASES, SANE). On average, 37% of the operated patients had a re-rupture at the ultrasound examination, with no significant difference between the two groups (p=1.00). Compared with the previous radiological control at the 2-year follow-up, new retears occurred in 6% of the patients that received PRP treatment, whereas in the control group the percentage raises to 14% (p=0.61). Conclusions: The clinical and radiological outcomes at the 10-year follow-up show a substantial uniformity of results between the two groups. The clinical differences that had been observed at 2-year follow-up disappeared at long term. A reduction in retear rate is observed at US evaluation in the PRP group at 10 years follow-up and this trend needs to be further analyzed. Patients’ satisfaction is still high 10 years after surgical treatment, in both groups.
机译:目的:尽管有关节镜旋转器袖带修复的技术进步,但经常发生修复的转子袖口的愈合或固定愈合不足。已经证明,在手术治疗中使用生物因素是有效地在术后期间增强肌腱愈合。该研究的目的是比较关节镜转子袖带修复的临床和放射性结果,并在10年随访时添加富含血小板的血浆(PRP)。方法:在研究中招募的53名患者,随机分为两组(PRP = 26;对照= 27),38次在指数程序后至少10年重新评估。临床评估通过:加州大学洛杉矶(UCLA)肩部得分,视觉模拟量表(VAS),简单的肩部测试(SST),恒门评分(CMS),单评价数值评价(SANE),美国肩部和肘部外科医生(ASES)和绑架和外部旋转等距强度。肌肉骨骼超声已被用于评估修复的袖带的完整性。结果:71岁的38名(71%)患者(PRP = 17; CONTROL = 21),中位数为71岁[64.75-76.50]。随访的满意度高(90%),两组之间没有统计学上的显着差异。我们报告了两组(PRP与控制):CMS(81.62 [72.47-85.75] vs 77.97 [69.52-82.55],UCLA(34 [29.00-35.00],33 [29.00-35.00]积分),VAS(0.34 [0.00-1.85] Vs 0.70 [0.00-2.45] cm),ASES(100.00 [94.17-100.00] Vs 93.33 [68.33-100.00点),SANE(100 [80-100] VS 80 [70 -90]点),SST(12.00 [11.00-12.00] VS 12.00 [9.00-12.00]点),肩部绑架强度(3.92±2.30 Vs 3.20 [1.72-4.65] kg),肩外旋转强度(5.31±2.77 Vs 4.36±2.05千克)。除了几个主观变量(ASES,SANE)之外,不可能找到分析的变量的统计学意义差异。平均而言,37%的操作患者在超声检查中重新破裂,两组之间没有显着差异(P = 1.00)。与以前的2年随访的放射控制相比,6%接受PRP治疗的患者发生了新的病因,而在对照组中,百分比升高至14%(P = 0.61)。结论:10年后续随访的临床和放射性结果表明两组之间的结果均匀性。在2年后观察到的临床差异长期消失。在美国在PRP组的美国评估中观察到固定率的降低,随访,需要进一步分析这种趋势。两组患者在手术治疗后10年后仍然高10年。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号